Dowling & Yahnke’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$40K Hold
10,000
﹤0.01% 369
2022
Q2
$45K Hold
10,000
﹤0.01% 371
2022
Q1
$85K Hold
10,000
﹤0.01% 369
2021
Q4
$88K Hold
10,000
﹤0.01% 372
2021
Q3
$104K Hold
10,000
0.01% 366
2021
Q2
$105K Buy
+10,000
New +$98.7K 0.01% 363

Other funds holding SRTA

Dowling & Yahnke's SRTA Position: Q3 2022 in Review

Dowling & Yahnke held its Strata Critical Medical Inc (SRTA) position steady in Q3 2022 at 10,000 shares worth $40K. The position accounts for ﹤0.01% of the portfolio, ranked #369.

Dowling & Yahnke first reported a position in SRTA in Q2 2021 and has held it in 6 quarters since. The position peaked at $105K in Q2 2021. 99 funds tracked by Wall St. Rank hold SRTA as of Q3 2022.

  • Dowling & Yahnke held 10,000 shares of Strata Critical Medical Inc worth $40K as of Q3 2022.
  • Dowling & Yahnke left its Strata Critical Medical Inc share count unchanged in Q3 2022.
  • Strata Critical Medical Inc made up ﹤0.01% of Dowling & Yahnke's portfolio in Q3 2022, its #369 holding.
  • Dowling & Yahnke first reported a position in Strata Critical Medical Inc in Q2 2021 and has held it in 6 quarters since.
  • Dowling & Yahnke's Strata Critical Medical Inc position peaked at $105K in Q2 2021.
  • 99 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2022.

Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.